Sonnet BioTherapeutics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Overview
    • Platform
    • Strategy
    • Progress
    • Publications
  • Pipeline
    • Overview
    • Clinical Trials
  • Partnering
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
Mar 14, 2023 4:31pm EDT

Sonnet BioTherapeutics to Present Clinical Data from the SB101 Study with SON-1010 at the AACR 2023 Annual Meeting

Feb 13, 2023 8:00am EST

Sonnet BioTherapeutics Provides Fiscal Year 2023 First Quarter Business and Earnings Update

Feb 08, 2023 8:00am EST

Sonnet BioTherapeutics Announces Pricing of $15.0 Million Underwritten Public Offering

Feb 01, 2023 8:00am EST

Sonnet BioTherapeutics Announces Successful Completion of Two IND-Enabling Toxicology Studies with SON-1210 in Non-Human Primates

Jan 19, 2023 8:00am EST

Sonnet BioTherapeutics Announces Pharmacokinetic and Pharmacodynamic Data in a Phase 1 Dose-Escalation Trial of SON-1010

Jan 09, 2023 8:00am EST

Sonnet BioTherapeutics Announces a Collaboration with Roche for the Clinical Evaluation of SON-1010 with atezolizumab in Ovarian Cancer

Dec 15, 2022 4:05pm EST

Sonnet BioTherapeutics Provides Fiscal Year 2022 Business and Financial Update

Nov 02, 2022 8:00am EDT

Sonnet BioTherapeutics Announces Interim Data in Two Phase 1 Dose-Escalation Trials of SON-1010

Nov 01, 2022 4:05pm EDT

Sonnet BioTherapeutics Announces Webcast to Discuss Interim Data from the Company’s Phase 1 Dose-Escalation Trials of SON-1010 on November 2, 2022

Oct 31, 2022 7:30am EDT

Sonnet BioTherapeutics Announces an Agreement with Janssen for the Evaluation of Three Sonnet Product Candidates

RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
Next
© 2023 Sonnet BioTherapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap